Qube Research & Technologies (QRT)
VAXX

Qube Research & Technologies (QRT)’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio VAXX Stock Details VAXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-125,401
Closed -$285K – 3166
2023
Q1 		$285K Buy
+125,401
New +$318K ﹤0.01% 1780

Other funds holding VAXX

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
PFO
Pathstone Family Office Englewood, New Jersey $13.1B AUM 21.02% 1-Year Est. Return
SM
Scoggin Management New York $1.04B AUM 232.32% 1-Year Est. Return

Qube Research & Technologies (QRT)'s VAXX Position: Q2 2023 in Review

Qube Research & Technologies (QRT) sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q2 2023, closing a stake of 125,401 shares — an estimated $285K sold.

Qube Research & Technologies (QRT) first reported a position in VAXX in Q1 2023 and held it in 1 quarter. The position peaked at $285K in Q1 2023. 49 funds tracked by Wall St. Rank hold VAXX as of Q2 2023.

  • Qube Research & Technologies (QRT) reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 125,401 Vaxxinity, Inc. Class A Common Stock shares in Q2 2023, an estimated $285K.
  • Qube Research & Technologies (QRT) first reported a position in Vaxxinity, Inc. Class A Common Stock in Q1 2023 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s Vaxxinity, Inc. Class A Common Stock position peaked at $285K in Q1 2023.
  • 49 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q2 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2023, filed 14 Aug 2023.